EPS for Emerson Electric Co. (EMR) Expected At $0.79; Last Week Bayer AG (ADR) (BAYRY) Coverage

October 27, 2017 - By Peter Erickson

Analysts expect Emerson Electric Co. (NYSE:EMR) to report $0.79 EPS on November, 7.They anticipate $0.17 EPS change or 17.71% from last quarter’s $0.96 EPS. EMR’s profit would be $505.66 million giving it 21.38 P/E if the $0.79 EPS is correct. After having $0.68 EPS previously, Emerson Electric Co.’s analysts see 16.18% EPS growth. About 2.43 million shares traded. Emerson Electric Co. (NYSE:EMR) has risen 18.47% since October 27, 2016 and is uptrending. It has outperformed by 1.77% the S&P500.

Among 6 analysts covering Bayer AG (OTCMKTS:BAYRY), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. Bayer AG had 8 analyst reports since September 21, 2015 according to SRatingsIntel. As per Tuesday, January 5, the company rating was downgraded by JP Morgan. The stock has “Hold” rating by HSBC on Friday, October 30. The firm earned “Sell” rating on Monday, September 21 by Zacks. As per Wednesday, December 2, the company rating was downgraded by Citigroup. The rating was upgraded by UBS to “Buy” on Wednesday, December 7. The firm has “Buy” rating by HSBC given on Thursday, December 10. The stock has “Buy” rating by Citigroup on Thursday, August 25. The stock of Bayer AG (ADR) (OTCMKTS:BAYRY) has “Buy” rating given on Monday, December 19 by Jefferies. See Bayer AG (ADR) (OTCMKTS:BAYRY) latest ratings:

About 331,189 shares traded. Bayer AG (ADR) (OTCMKTS:BAYRY) has 0.00% since October 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Bayer AG is a life science company. The Company’s divisions are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The company has market cap of $108.80 billion. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. It has a 21.07 P/E ratio. The Pharmaceuticals division also comprises the radiology business.

Investors sentiment increased to 1 in Q2 2017. Its up 0.12, from 0.88 in 2017Q1. It increased, as 60 investors sold Emerson Electric Co. shares while 407 reduced holdings. 86 funds opened positions while 383 raised stakes. 440.67 million shares or 1.25% more from 435.22 million shares in 2017Q1 were reported. Northstar Inv Advsrs Lc holds 1.76% or 145,918 shares in its portfolio. 5,075 were reported by Atwood And Palmer Incorporated. Fayerweather Charles holds 0.55% or 6,900 shares in its portfolio. Arrowgrass Capital Prtnrs (Us) L P has invested 0% in Emerson Electric Co. (NYSE:EMR). Eqis Capital Mgmt accumulated 3,949 shares or 0.01% of the stock. 11,052 were reported by Meiji Yasuda Asset Management Limited. Cobblestone Cap Advisors Limited Liability Company New York holds 0.24% of its portfolio in Emerson Electric Co. (NYSE:EMR) for 30,680 shares. Great West Life Assurance Can holds 502,720 shares. Folger Nolan Fleming Douglas Cap Mgmt holds 16,079 shares or 0.15% of its portfolio. Charter Trust Company, a New Hampshire-based fund reported 84,492 shares. 141,786 are owned by Asset Mngmt Inc. Grp One Trading Lp reported 0% of its portfolio in Emerson Electric Co. (NYSE:EMR). The New York-based Fagan Associates has invested 0.19% in Emerson Electric Co. (NYSE:EMR). Liberty Cap Mngmt holds 7,536 shares or 0.27% of its portfolio. 89,447 were accumulated by Mason Street Advsr Ltd.

Among 25 analysts covering Emerson Electric Co. (NYSE:EMR), 8 have Buy rating, 2 Sell and 15 Hold. Therefore 32% are positive. Emerson Electric Co. had 63 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, August 26 by Vertical Research. Citigroup maintained the stock with “Sell” rating in Monday, October 9 report. Cowen & Co maintained the shares of EMR in report on Wednesday, April 26 with “Hold” rating. Bank of America upgraded the stock to “Buy” rating in Tuesday, October 17 report. The rating was upgraded by UBS to “Neutral” on Wednesday, February 8. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, August 2. The company was downgraded on Friday, August 19 by Credit Suisse. As per Thursday, January 21, the company rating was initiated by Citigroup. The firm earned “Hold” rating on Thursday, June 22 by Cowen & Co. As per Wednesday, April 12, the company rating was maintained by RBC Capital Markets.